TXMD - TherapeuticsMD, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201712/31/201612/31/201512/31/2014
Total Revenue16,777.71319,356.4520,142.89815,026.219
Cost of Revenue2,636.9434,185.7084,506.6733,671.803
Gross Profit14,140.7715,170.74215,636.22511,354.416
Operating Expenses
Research Development33,852.99353,943.47772,042.77443,218.938
Selling General and Administrative57,703.3751,348.41428,721.23622,124.072
Non Recurring----
Others----
Total Operating Expenses94,406.423109,610.05105,333.08369,067.28
Operating Income or Loss-77,628.71-90,253.6-85,190.185-54,041.061
Income from Continuing Operations
Total Other Income/Expenses Net703.33378.141113.161-176.149
Earnings Before Interest and Taxes-77,628.71-90,253.6-85,190.185-54,041.061
Interest Expense----
Income Before Tax-76,925.38-89,875.459-85,077.024-54,217.21
Income Tax Expense----
Minority Interest----
Net Income From Continuing Ops-76,925.38-89,875.459-85,077.024-54,217.21
Non-recurring Events
Discontinued Operations----
Extraordinary Items----
Effect Of Accounting Changes----
Other Items----
Net Income
Net Income-76,925.38-89,875.459-85,077.024-54,217.21
Preferred Stock And Other Adjustments----
Net Income Applicable To Common Shares-76,925.38-89,875.459-85,077.024-54,217.21